Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Septerna is an innovative US-based biotechnology company specializing in the development of novel medicines through the precise control of G protein-coupled receptors (GPCRs). By leveraging its proprietary technological platform, Septerna unlocks new therapeutic pathways for treating human diseases.
Date confirmed from the company's own financial calendar.
Septerna is scheduled to report its next quarterly earnings on 10/08/2026.
Septerna last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.29 USD.
Septerna has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.